NASDAQ : ATRA
Atara Biotherapeutics, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 8.01 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 80.40M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Atara Biotherapeutics, Inc. (ATRA) reported revenue of 6.19M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 6.19M | 120.77M | 128.94M | 8.57M | 63.57M | 20.34M |
| Cost of Revenue | 1.53M | 46.15M | 155.28M | 228.05M | 269.99M | 282.00M |
| Gross Profit | 4.66M | 74.62M | -26.34M | -219.48M | -206.42M | -261.66M |
| Selling, General & Admin | 12.99M | 22.29M | 38.53M | 49.80M | 68.13M | 78.80M |
| Research & Development | 2.86M | 2.86M | 13.46M | |||
| Operating Expenses | 15.85M | 25.15M | 51.99M | 49.80M | 68.13M | 78.80M |
| Operating Income | -11.19M | 49.47M | -78.33M | -269.28M | -274.55M | -340.46M |
| Interest Expense | -2.82M | -3.79M | -4.62M | -5.29M | -373.00K | |
| Interest & Investment Income | 436.00K | 683.00K | 2.11M | 5.43M | 3.06M | 2.14M |
| Other Non Operating Income (Expenses) | -45.00K | -34.00K | 528.00K | -246.00K | -700.00K | |
| EBT Excluding Unusual Items | -13.62M | 46.33M | -80.31M | -269.38M | -272.56M | -338.33M |
| Merger & Restructuring Charges | -3.04M | -13.61M | -5.11M | -6.73M | -5.96M | |
| Gain (Loss) on Sale of Investments | -1.77M | |||||
| Gain (Loss) on Sale of Assets | 50.24M | |||||
| Pretax Income | -16.66M | 32.72M | -85.42M | -276.11M | -228.29M | -340.10M |
| Income Tax Expense | 29.00K | 31.00K | -12.00K | 15.00K | 12.00K | 46.00K |
| Net Income | -16.69M | 32.69M | -85.40M | -276.13M | -228.30M | -340.14M |
| Net Income to Common | -16.69M | 32.69M | -85.40M | -276.13M | -228.30M | -340.14M |
| Shares Outstanding (Basic) | 14.08M | 12.54M | 7.49M | 4.24M | 4.08M | 3.75M |
| Shares Outstanding (Diluted) | 14.08M | 12.72M | 7.49M | 4.24M | 4.08M | 3.75M |
| EPS (Basic) | -1.19 | 2.61 | -11.41 | -65.19 | -55.96 | -90.78 |
| EPS (Diluted) | -1.19 | 2.57 | -11.41 | -65.19 | -55.96 | -90.78 |
| Free Cash Flow | -21.89M | -50.94M | -68.96M | -194.20M | -274.62M | -231.10M |
| Free Cash Flow Per Share | -1.55 | -4.00 | -9.21 | -45.84 | -67.32 | -61.68 |
| Gross Margin | 75.27% | 61.79% | -20.43% | |||
| Operating Margin | -180.59% | 40.96% | -60.75% | -3,140.98% | -431.86% | -1,673.85% |
| Profit Margin | -269.42% | 27.07% | -66.23% | -3,220.88% | -359.12% | -1,672.28% |
| Free Cash Flow Margin | -353.49% | -42.18% | -53.49% | -2,265.25% | -431.98% | -1,136.19% |
| EBITDA | -11.06M | 51.59M | -73.28M | -264.45M | -268.90M | -331.12M |
| EBITDA Margin | -178.53% | 42.71% | -56.83% | |||
| D&A For EBITDA | 128.00K | 2.12M | 5.05M | 4.83M | 5.65M | 9.35M |
| EBIT | -11.19M | 49.47M | -78.33M | -269.28M | -274.55M | -340.46M |
| EBIT Margin | -180.59% | 40.96% | -60.75% | |||
| Effective Tax Rate | 0.10% | |||||
| Revenue as Reported | 120.77M | 120.77M | 128.94M | 8.57M | 63.57M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 3.22M | 8.48M | 25.03M | 25.84M | 92.94M | 106.08M |
| Short-Term Investments | 6.65M | 17.47M | 25.88M | 149.88M | 264.98M | |
| Cash & Short-Term Investments | 9.87M | 8.48M | 42.50M | 51.73M | 242.82M | 371.07M |
| Accounts Receivable | 318.00K | 1.25M | 1.48M | 34.11M | 40.22M | 986.00K |
| Other Receivables | 800.00K | 800.00K | ||||
| Receivables | 318.00K | 1.25M | 1.48M | 34.11M | 41.02M | 1.79M |
| Inventory | 10.65M | 9.71M | 1.59M | |||
| Restricted Cash | 146.00K | 146.00K | 146.00K | 194.00K | ||
| Other Current Assets | 3.34M | 2.48M | 10.12M | 6.18M | 9.51M | 11.57M |
| Total Current Assets | 13.53M | 12.21M | 64.89M | 101.87M | 295.08M | 384.62M |
| Property, Plant & Equipment | 6.73M | 7.14M | 41.10M | 58.79M | 74.32M | 79.94M |
| Other Long-Term Assets | 765.00K | 886.00K | 3.10M | 4.84M | 7.02M | 3.57M |
| Total Assets | 21.02M | 20.23M | 109.10M | 165.50M | 376.42M | 468.13M |
| Accounts Payable | 824.00K | 127.00K | 4.37M | 3.68M | 6.87M | 17.37M |
| Accrued Expenses | 3.12M | 3.30M | 20.82M | 48.53M | 50.41M | 44.91M |
| Current Portion of Leases | 1.10M | 1.03M | 13.92M | 12.18M | 13.64M | 2.75M |
| Current Unearned Revenue | 1.81M | 10.47M | 95.47M | 77.83M | 8.00M | 40.76M |
| Total Current Liabilities | 6.85M | 14.92M | 134.57M | 142.23M | 78.92M | 105.79M |
| Long-Term Leases | 8.78M | 9.35M | 29.91M | 45.69M | 58.06M | 25.52M |
| Long-Term Unearned Revenue | 40.51M | 32.67M | 38.62M | 72.19M | 107.24M | 55.71M |
| Other Long-Term Liabilities | 1.89M | 1.79M | 3.27M | 4.63M | 5.56M | 1.50M |
| Total Liabilities | 58.02M | 58.74M | 206.38M | 264.74M | 249.78M | 188.51M |
| Common Stock | 1.00K | 1.00K | 1.00K | 10.00K | 9.00K | |
| Additional Paid-In Capital | 1.99B | 1.98B | 1.96B | 1.87B | 1.82B | 1.74B |
| Retained Earnings | -2.03B | -2.02B | -2.05B | -1.97B | -1.69B | -1.46B |
| Comprehensive Income & Other | -2.00K | 1.00K | 8.00K | -204.00K | -2.07M | -368.00K |
| Shareholders' Equity | -37.00M | -38.50M | -97.28M | -99.23M | 126.64M | 279.61M |
| Total Liabilities & Equity | 21.02M | 20.23M | 109.10M | 165.50M | 376.42M | 468.13M |
| Total Debt | 9.88M | 10.38M | 43.83M | 57.87M | 71.70M | 28.27M |
| Net Cash (Debt) | -6.00K | -1.89M | -1.33M | -6.15M | 171.12M | 342.80M |
| Net Cash Per Share | -0.00 | -0.15 | -0.18 | -1.45 | 41.94 | 91.49 |
| Filing Date Shares Outstanding | 10.04M | 8.18M | 5.86M | 4.77M | 3.84M | 3.72M |
| Total Common Shares Outstanding | 9.44M | 7.32M | 5.86M | 4.26M | 3.84M | 3.67M |
| Working Capital | 6.68M | -2.71M | -69.68M | -40.36M | 216.16M | 278.83M |
| Book Value Per Share | -3.92 | -5.26 | -16.60 | -23.31 | 33.00 | 76.25 |
| Tangible Book Value | -37.00M | -38.50M | -97.28M | -99.23M | 126.64M | 279.61M |
| Tangible Book Value Per Share | -3.92 | -5.26 | -16.60 | -23.31 | 33.00 | 76.25 |
| Machinery | 219.00K | 17.67M | 18.66M | 17.82M | 26.05M | |
| Construction In Progress | 158.00K | 32.00K | 6.33M | |||
| Leasehold Improvements | 67.00K | 930.00K | 904.00K | 875.00K | 50.14M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -16.69M | 32.69M | -85.40M | -276.13M | -228.30M | -340.14M |
| Depreciation & Amortization | 128.00K | 2.12M | 5.05M | 4.83M | 5.65M | 9.35M |
| Loss (Gain) From Sale of Assets | -50.24M | |||||
| Asset Writedown & Restructuring Costs | 4.13M | |||||
| Loss (Gain) From Sale of Investments | -28.00K | 259.00K | -240.00K | 792.00K | 1.02M | 1.77M |
| Stock-Based Compensation | 3.88M | 9.75M | 27.00M | 45.39M | 53.84M | 53.87M |
| Other Operating Activities | 711.00K | 4.85M | 15.83M | 16.80M | 9.06M | 2.06M |
| Change in Accounts Receivable | -318.00K | 229.00K | 32.63M | 6.11M | -39.23M | 264.00K |
| Change in Inventory | 10.65M | -4.43M | -8.12M | -1.59M | ||
| Change in Accounts Payable | -477.00K | -4.24M | 687.00K | -3.13M | -9.21M | 9.07M |
| Change in Unearned Revenue | -832.00K | -94.38M | -20.30M | 30.39M | -11.47M | 35.22M |
| Change in Other Net Operating Assets | -8.28M | -17.00M | -39.53M | -9.92M | 32.00K | 8.04M |
| Operating Cash Flow | -21.89M | -50.94M | -68.72M | -192.98M | -270.43M | -220.52M |
| Capital Expenditures | -246.00K | -1.22M | -4.19M | -10.58M | ||
| Sale of Property, Plant & Equipment | 599.00K | 948.00K | 25.00K | 94.77M | ||
| Investment in Securities | -1.21M | 17.20M | 8.87M | 125.06M | 112.38M | 32.84M |
| Investing Cash Flow | -607.00K | 18.15M | 8.62M | 123.87M | 202.96M | 22.26M |
| Long-Term Debt Issued | 30.61M | |||||
| Long-Term Debt Repaid | -250.00K | -892.00K | -947.00K | -518.00K | -254.00K | |
| Net Debt Issued (Repaid) | -250.00K | -892.00K | -947.00K | 30.09M | -254.00K | |
| Issuance of Common Stock | 24.12M | 16.35M | 60.18M | 3.06M | 23.81M | 105.46M |
| Repurchase of Common Stock | -94.00K | -623.00K | -1.24M | |||
| Other Financing Activities | -15.30M | -1.00K | -7.00K | -13.00K | -192.00K | -17.00K |
| Financing Cash Flow | 8.82M | 16.10M | 59.28M | 2.01M | 53.08M | 103.94M |
| Net Cash Flow | -13.68M | -16.69M | -811.00K | -67.10M | -14.39M | -94.32M |
| Free Cash Flow | -21.89M | -50.94M | -68.96M | -194.20M | -274.62M | -231.10M |
| Free Cash Flow Margin | -353.49% | -42.18% | -53.49% | -2,265.25% | -431.98% | -1,136.19% |
| Free Cash Flow Per Share | -1.55 | -4.00 | -9.21 | -45.84 | -67.32 | -61.68 |
| Levered Free Cash Flow | -12.52M | -47.68M | -1.68M | -55.72M | -192.99M | -128.98M |
| Unlevered Free Cash Flow | -10.76M | -45.31M | 1.21M | -52.42M | -192.76M | -128.98M |
| Cash Interest Paid | 397.00K | 286.00K | 685.00K | 447.00K | 335.00K | 32.00K |
| Cash Income Tax Paid | 188.00K | 190.00K | 24.00K | 2.00K | 19.00K | 15.00K |
| Change in Working Capital | -9.90M | -104.73M | -30.96M | 15.34M | -61.47M | 52.58M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 80.40M | 130.43M | 76.66M | 52.27M | 311.20M | 1.39B |
| Enterprise Value | 80.41M | 133.68M | 59.37M | 11.66M | 122.49M | 1.06B |
| Last Close Price | 8.01 | 18.09 | 13.31 | 12.82 | 82.00 | 394.00 |
| PE Ratio | 3.99 | |||||
| Forward PE | 26.92 | 19.66 | 0.30 | |||
| PS Ratio | 12.98 | 1.08 | 0.59 | 6.10 | 4.89 | 68.51 |
| PB Ratio | -3.39 | -0.79 | -0.53 | 2.46 | 4.98 | |
| P/TBV Ratio | 2.46 | 4.98 | ||||
| EV/Sales Ratio | 12.98 | 1.11 | 0.46 | 1.36 | 1.93 | 52.15 |
| EV/EBITDA Ratio | 2.59 | |||||
| EV/EBIT Ratio | 2.70 | |||||
| Debt / Equity Ratio | -0.27 | -0.27 | -0.45 | -0.58 | 0.57 | 0.10 |
| Debt / EBITDA Ratio | 0.18 | |||||
| Net Debt / Equity Ratio | 0.00 | -0.05 | -0.01 | -0.06 | -1.35 | -1.23 |
| Net Debt / EBITDA Ratio | -0.00 | 0.04 | -0.02 | -0.02 | 0.64 | 1.03 |
| Net Debt / FCF Ratio | 0.00 | -0.04 | -0.02 | -0.03 | 0.62 | 1.48 |
| Asset Turnover | 0.21 | 1.87 | 0.94 | 0.03 | 0.15 | 0.04 |
| Inventory Turnover | 15.25 | 40.39 | ||||
| Quick Ratio | 1.49 | 0.65 | 0.33 | 0.60 | 3.60 | 3.52 |
| Current Ratio | 1.98 | 0.82 | 0.48 | 0.72 | 3.74 | 3.64 |
| Return on Equity (ROE) | -2,014.86% | -112.39% | -91.69% | |||
| Return on Assets (ROA) | -24.14% | 47.81% | -35.66% | -62.11% | -40.63% | -40.29% |
| Return on Invested Capital (ROIC) | -78.42% | -1,156.78% | ||||
| Return on Capital Employed (ROCE) | -78.90% | 931.10% | 307.50% | -1,156.80% | -92.30% | -94.00% |
| Earnings Yield | -14.84% | 25.06% | -111.40% | -528.31% | -73.36% | -24.41% |
| FCF Yield | -27.23% | -39.05% | -89.96% | -371.56% | -88.25% | -16.59% |
| Buyback Yield / Dilution | -36.26% | -69.84% | -76.77% | -3.83% | -8.88% | -26.63% |